Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Riccardo Zanni is active.

Publication


Featured researches published by Riccardo Zanni.


Current Computer - Aided Drug Design | 2014

QSAR multi-target in drug discovery: a review.

Riccardo Zanni; María Gálvez-Llompart; Jorge Gálvez; Ramón García-Domenech

The main purpose of the present review is to summarize the most significant works up to date in the field of multi-target QSAR (mt-QSAR), in order to emphasize the importance that this technique has acquired over the last decade. Unlike traditional QSAR techniques, mt-QSAR permits to calculate the probability of activity of a given compound against different biological or pharmacological targets. In simple terms, a single equation for multiple outputs. To emphasize more the importance of the mt-QSAR in the field of drug discovery, we also present a novel mt-QSAR model, made on purpose by our research group, for the prediction of the susceptibility of Gram + and Gram - anaerobic bacteria.


Expert Opinion on Drug Discovery | 2015

Latest advances in molecular topology applications for drug discovery

Riccardo Zanni; María Gálvez-Llompart; Ramón García-Domenech; Jorge Gálvez

Introduction: Molecular topology (MT) has emerged in recent years as a powerful approach for the in silico generation of new drugs. In the last decade, its application has become more and more popular among the leading research groups in the field of quantitative structure–activity relationships (QSAR) and drug design. This has, in turn, contributed to the rapid development of new techniques and applications of MT in QSAR studies, as well as the introduction of new topological indices. Areas covered: This review collates the main innovative techniques in the field of MT and provides a description of the novel topological indices recently introduced, through an exhaustive recompilation of the most significant works carried out by the leading research groups in the field of drug design and discovery. The objective is to show the importance of MT methods combined with the effectiveness of the descriptors. Expert opinion: Recent years have witnessed a remarkable rise in QSAR methods based on MT and its application to drug design. New methodologies have been introduced in the area such as QSAR multi-target, Markov networks or perturbation methods. Moreover, novel topological indices, such as Bourgas’ descriptors and other new concepts as the derivative of a graph or cliques capable to distinguish between conformers, have also been introduced. New drugs have also been discovered, including anticonvulsants, anineoplastics, antimalarials or antiallergics, just to name a few. In the authors’ opinion, MT and QSAR have moved from an attractive possibility to representing a foundation stone in the process of drug discovery.


Molecular Diversity | 2015

Predicting antiprotozoal activity of benzyl phenyl ether diamine derivatives through QSAR multi-target and molecular topology

Ramón García-Domenech; Riccardo Zanni; María Gálvez-Llompart; Jorge Gálvez

Multi-target QSAR is a novel approach that can predict simultaneously the activity of a given chemical compound on different pharmacological targets. In this work, we have used molecular topology and statistical tools such as multilinear regression analysis and artificial neural networks, to achieve a multi-target QSAR model capable to predict the antiprotozoal activity of a group of benzyl phenyl ether diamine derivatives. The activity was related to three parasites with a high prevalence rate in humans: Trypanosoma brucei rhodesiense, Plasmodium falciparum, and Leishmania donovani. The multi-target model showed a high regression coefficient (


Drug Discovery Today: Technologies | 2013

Molecular topology - dissimilar similarities.

Jorge Gálvez; María Gálvez-Llompart; Riccardo Zanni; Ramón García-Domenech


PLOS ONE | 2015

Novel Cancer Chemotherapy Hits by Molecular Topology: Dual Akt and Beta-Catenin Inhibitors

Riccardo Zanni; María Gálvez-Llompart; Cecilia Morell; Nieves Rodríguez-Henche; Inés Díaz-Laviada; Maria Carmen Recio-Iglesias; Ramón García-Domenech; Jorge Gálvez

{R}^{2} = 0.9644


Expert Opinion on Drug Discovery | 2013

QSAR methods for the discovery of new inflammatory bowel disease drugs

Ramón García-Domenech; María Gálvez-Llompart; Riccardo Zanni; María del Carmen Recio; Jorge Gálvez


Combinatorial Chemistry & High Throughput Screening | 2013

Modeling Anti-Allergic Natural Compounds by Molecular Topology

Ramón García-Domenech; Riccardo Zanni; María Gálvez-Llompart; J. Vicente de Julian-Ortiz

R2=0.9644 and


Current Drug Metabolism | 2014

The Prediction of Human Intestinal Absorption Based on the Molecular Structure

J. Vicente de Julian-Ortiz; Riccardo Zanni; María Gálvez-Llompart; Ramón García-Domenech


Expert Opinion on Drug Discovery | 2013

Advances in the molecular modeling and quantitative structure–activity relationship-based design for antihistamines

Jorge Gálvez; María Gálvez-Llompart; Riccardo Zanni; Ramón García-Domenech

{R}^{2} = 0.9235


Molecular Diversity | 2018

Molecular topology and QSAR multi-target analysis to boost the in silico research for fungicides in agricultural chemistry

Riccardo Zanni; María Gálvez-Llompart; Inma Garcia-Pereira; Jorge Gálvez; Ramón García-Domenech

Collaboration


Dive into the Riccardo Zanni's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Esther Recacha

Spanish National Research Council

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge